Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
67.96
+3.77 (5.87%)
At close: Feb 21, 2025, 4:00 PM
68.25
+0.29 (0.43%)
After-hours: Feb 21, 2025, 4:51 PM EST
Verona Pharma Revenue
Verona Pharma had revenue of $5.62M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $5.62M, up 1,127.95% year-over-year.
Revenue (ttm)
$5.62M
Revenue Growth
+1,127.95%
P/S Ratio
988.84
Revenue / Employee
$71,190
Employees
79
Market Cap
5.56B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
VRNA News
- 4 days ago - Verona Pharma Announces March 2025 Investor Conference Participation - GlobeNewsWire
- 9 days ago - Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 6 weeks ago - Verona Pharma's Ohtuvayre Defies Expectations In Q4, But Stock Alpha May Now Be Limited - Seeking Alpha
- 6 weeks ago - Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights - GlobeNewsWire
- 3 months ago - Verona Pharma Announces December 2024 Investor Conference Participation - GlobeNewsWire
- 3 months ago - Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value - CNBC
- 3 months ago - Verona Pharma to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 3 months ago - Verona Pharma plc (VRNA) Q3 2024 Earnings Call Transcript - Seeking Alpha